Tuesday, April 14, 2015 8:43:39 AM
I believe that no one will be able to answer your questions.
Unfortunately, in recent years:
- No news
- no one knows the name of CEO, and if there exists a CEO
- No one answers at phone
- No one is present in the office
- The website has been overshadowed
- Web domain expires in August
In July 2014, I sent email to big Pharma ROCHE about AVAX. They replied to be interested to buy AVAX or for partnership.
http://www.roche.com/research_and_development/partnering/partnering-what.htm
Last month, I sent a request to CTCA to know the status of two clinical trials (O-vax and M-vax). Unfortunately, they replied in the singular ...:
"Unfortunately, this study is no longer accruing patients."
My question: Which one study ( O-vax or M-vax ) ?
-------------------------------------------------- ------------
If you do not own shares of AVAX, I will suggest you to bet on another horse …
Otherwise, you buy shares AVAX as a lottery ticket !
However, I suggest you contact the "Yahoo's board." There are more investors who follow AVAX:
http://finance.yahoo.com/mb/forumview/?&bn=f9d0c3ff-6279-39aa-bcf0-63d515ff7441
Good luck !
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM